131 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
, you and the Company are parties to an employment agreement (the “Employment Agreement”) that provides for severance pay and benefits upon certain … , if you enter into this Agreement and satisfy the conditions set forth in Section 2 below, the Company will provide you with the Severance Benefits
10-K
2016 FY
EX-10.21
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
(the “Company”) on March 10, 2017 to provide Executives with the opportunity to receive severance benefits following termination of employment under certain … Agreement.
(b) Company’s Obligations Upon Cessation of the Employment Period.
(i) Accrued Benefits. Unless stated otherwise, where terms
10-K
2016 FY
EX-10.17
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
APPOINTMENT
DURATION AND WARRANTIES
SCOPE OF THE EMPLOYMENT
HOURS AND PLACE OF WORK
REMUNERATION
PENSION AND OTHER BENEFITS
BONUS
EXPENSES
HOLIDAY … or otherwise to any sum or other benefits to compensate him for the loss of any rights under the Share Scheme.
7. PENSION AND OTHER BENEFITS
7.1
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
AND WARRANTIES
SCOPE OF THE EMPLOYMENT
HOURS AND PLACE OF WORK
REMUNERATION
PENSION AND OTHER BENEFITS
EXPENSES
HOLIDAY
INCAPACITY
DEDUCTIONS
RESTRICTIONS … to have waived any entitlement, by way of compensation for loss of office or otherwise to any sum or other benefits to compensate him for the loss of any
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
Therapeutics plc (the “Company”) on December 4, 2019 to provide Senior Vice Presidents (“SVPs”) with the opportunity to receive severance benefits … of the relevant SVP’s Employment Agreement.
(b) Company’s Obligations Upon Cessation of the Employment Period.
(i) Accrued Benefits. Unless stated
8-K
EX-10.1
h2hid
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
10-K
EX-10.20
efw0ec53rktltlm it
13 Mar 17
Annual report
12:00am
8-K
EX-10.1
42dzxguij fxqj9icbnr
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.1
20d32 8djy7gf
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
8-K
EX-10.01
vtbqoq mga7v9
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.1
y99jdxzzfxuwpbrm7
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
10-K
EX-10.19
yfh441
13 Mar 17
Annual report
12:00am